| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| BRCA1 Protein | 11 | 2011 | 58 | 1.970 |
Why?
|
| Transcription Factors | 26 | 2001 | 735 | 1.300 |
Why?
|
| Proto-Oncogene Proteins | 17 | 2001 | 257 | 1.130 |
Why?
|
| DNA-Binding Proteins | 23 | 2001 | 561 | 1.110 |
Why?
|
| Fragaria | 1 | 2025 | 2 | 0.940 |
Why?
|
| Metabolomics | 1 | 2025 | 95 | 0.880 |
Why?
|
| Fruit | 1 | 2025 | 178 | 0.820 |
Why?
|
| Retroviridae Proteins, Oncogenic | 10 | 1994 | 27 | 0.730 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 2 | 2011 | 15 | 0.660 |
Why?
|
| Alternative Splicing | 8 | 2009 | 94 | 0.640 |
Why?
|
| Breast Neoplasms | 9 | 2011 | 1723 | 0.610 |
Why?
|
| Transcriptional Activation | 11 | 2009 | 173 | 0.570 |
Why?
|
| Trans-Activators | 12 | 2004 | 192 | 0.530 |
Why?
|
| ets-Domain Protein Elk-1 | 9 | 2009 | 27 | 0.510 |
Why?
|
| Cell Nucleus | 2 | 2011 | 383 | 0.430 |
Why?
|
| Transcription, Genetic | 13 | 2004 | 592 | 0.420 |
Why?
|
| Nuclear Proteins | 8 | 2001 | 333 | 0.410 |
Why?
|
| Genetic Variation | 3 | 2022 | 430 | 0.400 |
Why?
|
| Apoptosis | 8 | 2011 | 1568 | 0.390 |
Why?
|
| DNA | 12 | 1996 | 592 | 0.380 |
Why?
|
| Estrogen Receptor alpha | 2 | 2011 | 121 | 0.360 |
Why?
|
| Genes, BRCA1 | 3 | 2009 | 19 | 0.360 |
Why?
|
| Recombinant Fusion Proteins | 12 | 2011 | 296 | 0.350 |
Why?
|
| Proto-Oncogenes | 5 | 1991 | 19 | 0.330 |
Why?
|
| Neoplasm Proteins | 6 | 1999 | 228 | 0.320 |
Why?
|
| SUMO-1 Protein | 1 | 2009 | 16 | 0.300 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2001 | 61 | 0.280 |
Why?
|
| Cyclins | 2 | 1999 | 34 | 0.280 |
Why?
|
| Cell Proliferation | 2 | 2011 | 1455 | 0.280 |
Why?
|
| Flavonoids | 2 | 2025 | 100 | 0.260 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2011 | 968 | 0.250 |
Why?
|
| Ovarian Neoplasms | 4 | 2007 | 415 | 0.240 |
Why?
|
| Anthocyanins | 1 | 2025 | 6 | 0.230 |
Why?
|
| Proanthocyanidins | 1 | 2025 | 4 | 0.230 |
Why?
|
| 3T3 Cells | 10 | 1998 | 64 | 0.230 |
Why?
|
| Mitochondria | 1 | 2009 | 523 | 0.230 |
Why?
|
| Transfection | 9 | 2011 | 532 | 0.230 |
Why?
|
| Crops, Agricultural | 2 | 2024 | 36 | 0.230 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2025 | 65 | 0.220 |
Why?
|
| COS Cells | 4 | 2011 | 68 | 0.220 |
Why?
|
| Animals | 27 | 2011 | 16992 | 0.220 |
Why?
|
| Translocation, Genetic | 5 | 2004 | 40 | 0.220 |
Why?
|
| Plant Diseases | 2 | 2022 | 65 | 0.210 |
Why?
|
| DNA Shuffling | 1 | 2024 | 1 | 0.210 |
Why?
|
| Bayes Theorem | 1 | 2024 | 126 | 0.210 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2011 | 220 | 0.200 |
Why?
|
| Genes, fos | 2 | 2001 | 14 | 0.200 |
Why?
|
| Oncogenes | 5 | 1993 | 44 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 5 | 1999 | 526 | 0.190 |
Why?
|
| Environmental Exposure | 1 | 2024 | 256 | 0.180 |
Why?
|
| Citrus | 1 | 2021 | 14 | 0.180 |
Why?
|
| Antioxidants | 1 | 2025 | 443 | 0.180 |
Why?
|
| Humans | 39 | 2024 | 43102 | 0.180 |
Why?
|
| Prostatic Neoplasms | 2 | 2011 | 1092 | 0.180 |
Why?
|
| Molecular Sequence Data | 15 | 1998 | 1542 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 21 | 3 | 1994 | 9 | 0.170 |
Why?
|
| Tumor Cells, Cultured | 8 | 2001 | 508 | 0.170 |
Why?
|
| Cell Line, Tumor | 5 | 2011 | 2676 | 0.170 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 1998 | 110 | 0.170 |
Why?
|
| Base Sequence | 14 | 2004 | 983 | 0.160 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 1998 | 165 | 0.160 |
Why?
|
| Proteins | 3 | 1992 | 382 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-ets | 6 | 2011 | 16 | 0.160 |
Why?
|
| Microscopy, Fluorescence | 2 | 2011 | 256 | 0.150 |
Why?
|
| Biosensing Techniques | 1 | 2022 | 136 | 0.150 |
Why?
|
| Metal Nanoparticles | 1 | 2023 | 230 | 0.150 |
Why?
|
| Mice | 15 | 2007 | 6644 | 0.150 |
Why?
|
| RNA, Antisense | 2 | 1996 | 18 | 0.150 |
Why?
|
| Cell Line | 9 | 1998 | 1410 | 0.150 |
Why?
|
| Binding Sites | 8 | 1999 | 671 | 0.150 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1993 | 41 | 0.150 |
Why?
|
| Bacteria | 1 | 2022 | 293 | 0.140 |
Why?
|
| Sequence Homology, Nucleic Acid | 5 | 1998 | 88 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2001 | 137 | 0.140 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1997 | 26 | 0.130 |
Why?
|
| Female | 14 | 2024 | 24698 | 0.130 |
Why?
|
| Cell Survival | 3 | 2011 | 945 | 0.130 |
Why?
|
| Protein Biosynthesis | 3 | 1990 | 132 | 0.130 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1994 | 139 | 0.120 |
Why?
|
| Melphalan | 1 | 2015 | 1 | 0.120 |
Why?
|
| Vidarabine | 1 | 2015 | 2 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 1997 | 321 | 0.110 |
Why?
|
| Ribonucleoproteins | 4 | 1996 | 31 | 0.110 |
Why?
|
| Collateral Ligaments | 1 | 2014 | 1 | 0.110 |
Why?
|
| Cell Cycle Proteins | 1 | 1997 | 241 | 0.110 |
Why?
|
| Knee Injuries | 1 | 2014 | 5 | 0.110 |
Why?
|
| CREB-Binding Protein | 2 | 2009 | 13 | 0.110 |
Why?
|
| Immediate-Early Proteins | 2 | 1993 | 49 | 0.110 |
Why?
|
| Protein Binding | 3 | 2011 | 1082 | 0.110 |
Why?
|
| Seminal Vesicle Secretory Proteins | 2 | 1985 | 7 | 0.110 |
Why?
|
| Amino Acid Sequence | 11 | 1998 | 1180 | 0.100 |
Why?
|
| RNA-Binding Proteins | 4 | 1995 | 161 | 0.100 |
Why?
|
| Fungal Proteins | 1 | 1993 | 142 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 220 | 0.100 |
Why?
|
| Avian leukosis virus | 2 | 1990 | 7 | 0.100 |
Why?
|
| Retroviridae Proteins | 2 | 1989 | 7 | 0.090 |
Why?
|
| BRCA2 Protein | 3 | 2009 | 50 | 0.090 |
Why?
|
| Mice, Nude | 3 | 2007 | 408 | 0.090 |
Why?
|
| Serum Response Factor | 3 | 2001 | 10 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2011 | 60 | 0.090 |
Why?
|
| Cell Division | 2 | 2007 | 311 | 0.090 |
Why?
|
| Phosphoproteins | 1 | 1993 | 206 | 0.090 |
Why?
|
| Point Mutation | 1 | 2011 | 98 | 0.090 |
Why?
|
| Cytoplasm | 1 | 2011 | 154 | 0.090 |
Why?
|
| Valproic Acid | 1 | 2011 | 21 | 0.090 |
Why?
|
| Hydroxamic Acids | 1 | 2011 | 33 | 0.090 |
Why?
|
| Cloning, Molecular | 8 | 1999 | 314 | 0.080 |
Why?
|
| RNA Splicing | 2 | 1988 | 41 | 0.080 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2011 | 46 | 0.080 |
Why?
|
| RNA Interference | 1 | 2011 | 247 | 0.080 |
Why?
|
| Models, Genetic | 2 | 2009 | 183 | 0.080 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2001 | 17 | 0.080 |
Why?
|
| K562 Cells | 1 | 2009 | 32 | 0.080 |
Why?
|
| HL-60 Cells | 1 | 2009 | 33 | 0.080 |
Why?
|
| Growth Inhibitors | 1 | 2009 | 29 | 0.080 |
Why?
|
| X Chromosome | 1 | 1989 | 30 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2009 | 139 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 1988 | 31 | 0.070 |
Why?
|
| Soft Tissue Neoplasms | 2 | 2001 | 15 | 0.070 |
Why?
|
| Glutathione Transferase | 3 | 2001 | 90 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1988 | 38 | 0.070 |
Why?
|
| Acetyltransferases | 2 | 1998 | 27 | 0.070 |
Why?
|
| Male | 7 | 2024 | 23409 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2009 | 91 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2009 | 185 | 0.070 |
Why?
|
| Hela Cells | 1 | 2009 | 376 | 0.070 |
Why?
|
| Escherichia coli | 3 | 1991 | 460 | 0.070 |
Why?
|
| Leukemia | 2 | 1998 | 54 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2001 | 108 | 0.070 |
Why?
|
| Transplantation, Heterologous | 1 | 2007 | 98 | 0.060 |
Why?
|
| DNA Damage | 1 | 2009 | 356 | 0.060 |
Why?
|
| Phosphorylation | 3 | 1994 | 986 | 0.060 |
Why?
|
| Plasmids | 4 | 2001 | 244 | 0.060 |
Why?
|
| Simian virus 40 | 1 | 1986 | 35 | 0.060 |
Why?
|
| Receptors, Estrogen | 1 | 2007 | 183 | 0.060 |
Why?
|
| DNA, Complementary | 5 | 1998 | 196 | 0.060 |
Why?
|
| Gelsolin | 1 | 2004 | 4 | 0.060 |
Why?
|
| Cystic Fibrosis | 1 | 2024 | 28 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2001 | 883 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2004 | 49 | 0.050 |
Why?
|
| Genome, Plant | 1 | 2024 | 29 | 0.050 |
Why?
|
| Mutation | 1 | 2009 | 1177 | 0.050 |
Why?
|
| Melanoma | 2 | 1996 | 110 | 0.050 |
Why?
|
| Plants, Genetically Modified | 1 | 2024 | 51 | 0.050 |
Why?
|
| Lung Diseases | 1 | 2024 | 63 | 0.050 |
Why?
|
| Young Adult | 3 | 2024 | 5080 | 0.050 |
Why?
|
| Air Pollution | 1 | 2024 | 87 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2024 | 2544 | 0.050 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 4 | 1998 | 10 | 0.050 |
Why?
|
| Oxylipins | 1 | 2023 | 4 | 0.050 |
Why?
|
| Hydroponics | 1 | 2023 | 7 | 0.050 |
Why?
|
| Lignin | 1 | 2023 | 8 | 0.050 |
Why?
|
| Adolescent | 3 | 2024 | 6081 | 0.050 |
Why?
|
| Rhizoctonia | 1 | 2022 | 1 | 0.050 |
Why?
|
| Cyclopentanes | 1 | 2023 | 26 | 0.050 |
Why?
|
| Rats | 3 | 1998 | 3735 | 0.050 |
Why?
|
| DNA, Ribosomal | 1 | 2022 | 39 | 0.050 |
Why?
|
| Air Pollutants | 1 | 2024 | 130 | 0.050 |
Why?
|
| Acetates | 1 | 2023 | 32 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 1994 | 462 | 0.050 |
Why?
|
| Semen | 1 | 1983 | 57 | 0.050 |
Why?
|
| Recombinant Proteins | 3 | 1993 | 518 | 0.050 |
Why?
|
| Precipitin Tests | 2 | 2001 | 52 | 0.050 |
Why?
|
| Silver | 1 | 2023 | 61 | 0.050 |
Why?
|
| Genetics, Population | 1 | 2022 | 121 | 0.050 |
Why?
|
| Gene Expression Regulation | 4 | 1992 | 1070 | 0.050 |
Why?
|
| Child | 2 | 2024 | 3443 | 0.050 |
Why?
|
| Anti-Infective Agents | 1 | 1983 | 75 | 0.050 |
Why?
|
| Sequence Deletion | 2 | 1999 | 93 | 0.050 |
Why?
|
| Technology | 1 | 2022 | 29 | 0.050 |
Why?
|
| Sarcoma, Clear Cell | 1 | 2001 | 2 | 0.050 |
Why?
|
| Bacterial Proteins | 1 | 1987 | 595 | 0.040 |
Why?
|
| Phenols | 1 | 2023 | 107 | 0.040 |
Why?
|
| Genes, p53 | 1 | 2001 | 27 | 0.040 |
Why?
|
| Disease Progression | 1 | 2024 | 667 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2024 | 423 | 0.040 |
Why?
|
| RNA-Binding Protein FUS | 2 | 1998 | 5 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2004 | 42 | 0.040 |
Why?
|
| Structure-Activity Relationship | 2 | 1993 | 506 | 0.040 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2001 | 29 | 0.040 |
Why?
|
| Response Elements | 1 | 2001 | 55 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1063 | 0.040 |
Why?
|
| Plants | 1 | 2022 | 113 | 0.040 |
Why?
|
| Restriction Mapping | 2 | 1991 | 42 | 0.040 |
Why?
|
| Genetic Vectors | 3 | 1998 | 165 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1999 | 56 | 0.040 |
Why?
|
| Models, Biological | 2 | 2011 | 712 | 0.040 |
Why?
|
| Phylogeny | 1 | 2022 | 769 | 0.040 |
Why?
|
| Chromosome Mapping | 2 | 1989 | 199 | 0.040 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 2 | 1998 | 22 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1998 | 47 | 0.040 |
Why?
|
| RNA, Messenger | 4 | 1998 | 1271 | 0.030 |
Why?
|
| E2F5 Transcription Factor | 1 | 1997 | 2 | 0.030 |
Why?
|
| E2F4 Transcription Factor | 1 | 1997 | 2 | 0.030 |
Why?
|
| Transcription Factor DP1 | 1 | 1997 | 3 | 0.030 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 1997 | 3 | 0.030 |
Why?
|
| Blood Physiological Phenomena | 1 | 1997 | 6 | 0.030 |
Why?
|
| E2F2 Transcription Factor | 1 | 1997 | 7 | 0.030 |
Why?
|
| E2F3 Transcription Factor | 1 | 1997 | 12 | 0.030 |
Why?
|
| E2F Transcription Factors | 1 | 1997 | 11 | 0.030 |
Why?
|
| E2F1 Transcription Factor | 1 | 1997 | 22 | 0.030 |
Why?
|
| Tyrosine | 1 | 1997 | 120 | 0.030 |
Why?
|
| Biological Transport | 1 | 1997 | 204 | 0.030 |
Why?
|
| Calcimycin | 1 | 1996 | 11 | 0.030 |
Why?
|
| Ionophores | 1 | 1996 | 11 | 0.030 |
Why?
|
| Protein Structure, Secondary | 2 | 1993 | 182 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1996 | 10 | 0.030 |
Why?
|
| Acetylation | 2 | 2011 | 107 | 0.030 |
Why?
|
| Macromolecular Substances | 2 | 1993 | 92 | 0.030 |
Why?
|
| Early Growth Response Protein 1 | 2 | 1993 | 11 | 0.030 |
Why?
|
| Chimerism | 1 | 2015 | 2 | 0.030 |
Why?
|
| Transplantation Conditioning | 1 | 2015 | 9 | 0.030 |
Why?
|
| RNA-Binding Protein EWS | 4 | 1996 | 8 | 0.030 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 4 | 1996 | 13 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1994 | 8 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1991 | 50 | 0.030 |
Why?
|
| Leukemia, Myeloid | 1 | 1994 | 7 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2009 | 423 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 1996 | 238 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 54 | 0.030 |
Why?
|
| Fibroblasts | 1 | 1996 | 281 | 0.030 |
Why?
|
| Kinetics | 1 | 1996 | 695 | 0.030 |
Why?
|
| ets-Domain Protein Elk-4 | 1 | 1993 | 2 | 0.030 |
Why?
|
| Quail | 1 | 1993 | 4 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2009 | 161 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1994 | 105 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 1993 | 17 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 1993 | 70 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2014 | 341 | 0.020 |
Why?
|
| Friend murine leukemia virus | 1 | 1992 | 2 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1993 | 95 | 0.020 |
Why?
|
| Viral Structural Proteins | 1 | 1992 | 17 | 0.020 |
Why?
|
| DNA, Viral | 2 | 1986 | 311 | 0.020 |
Why?
|
| Genes, Viral | 1 | 1992 | 61 | 0.020 |
Why?
|
| Virus Integration | 1 | 1992 | 65 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1992 | 113 | 0.020 |
Why?
|
| Incidence | 1 | 2014 | 1078 | 0.020 |
Why?
|
| Caspase 7 | 1 | 2011 | 18 | 0.020 |
Why?
|
| Spherocytosis, Hereditary | 1 | 1971 | 2 | 0.020 |
Why?
|
| Erythrocytes, Abnormal | 1 | 1971 | 2 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1991 | 83 | 0.020 |
Why?
|
| p21-Activated Kinases | 1 | 2011 | 21 | 0.020 |
Why?
|
| Hospitalization | 1 | 2014 | 485 | 0.020 |
Why?
|
| Reticulocytes | 1 | 1990 | 9 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2011 | 61 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2015 | 1604 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2015 | 1546 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2011 | 227 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 1990 | 68 | 0.020 |
Why?
|
| Erythrocytes | 1 | 1971 | 126 | 0.020 |
Why?
|
| Rabbits | 1 | 1990 | 278 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 1612 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1990 | 416 | 0.020 |
Why?
|
| DNA Probes | 1 | 1989 | 32 | 0.020 |
Why?
|
| Glycosylation | 1 | 2009 | 113 | 0.020 |
Why?
|
| Chick Embryo | 1 | 1989 | 79 | 0.020 |
Why?
|
| Chromosome Banding | 1 | 1988 | 6 | 0.020 |
Why?
|
| Hybrid Cells | 1 | 1988 | 20 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1988 | 68 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1988 | 168 | 0.020 |
Why?
|
| Adult | 2 | 2015 | 13872 | 0.020 |
Why?
|
| Avian myeloblastosis virus | 1 | 1988 | 5 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1988 | 124 | 0.020 |
Why?
|
| Chickens | 1 | 1989 | 161 | 0.020 |
Why?
|
| Poly A | 1 | 1987 | 33 | 0.020 |
Why?
|
| Bacteriophage lambda | 1 | 1987 | 12 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1987 | 197 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 1986 | 17 | 0.020 |
Why?
|
| Poly U | 1 | 1985 | 2 | 0.010 |
Why?
|
| Isoelectric Focusing | 1 | 1985 | 13 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1985 | 24 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1985 | 51 | 0.010 |
Why?
|
| Ribonucleases | 1 | 1985 | 32 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 1985 | 44 | 0.010 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 1985 | 30 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2004 | 14 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2004 | 72 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 66 | 0.010 |
Why?
|
| RNA, Viral | 1 | 1986 | 321 | 0.010 |
Why?
|
| Viral Proteins | 1 | 1986 | 190 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 294 | 0.010 |
Why?
|
| Actins | 1 | 2004 | 164 | 0.010 |
Why?
|
| United States | 1 | 2014 | 5205 | 0.010 |
Why?
|
| Coliphages | 1 | 1983 | 9 | 0.010 |
Why?
|
| Cell-Free System | 1 | 1983 | 15 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 455 | 0.010 |
Why?
|
| RNA | 1 | 1985 | 266 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 12222 | 0.010 |
Why?
|
| TATA Box | 1 | 1998 | 3 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1999 | 141 | 0.010 |
Why?
|
| Exons | 1 | 1999 | 92 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1999 | 76 | 0.010 |
Why?
|
| Retroviridae | 1 | 1998 | 25 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 1998 | 27 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 1124 | 0.010 |
Why?
|
| Histone Acetyltransferases | 1 | 1998 | 21 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1998 | 53 | 0.010 |
Why?
|
| Cell Lineage | 1 | 1998 | 104 | 0.010 |
Why?
|
| Breast | 1 | 1999 | 139 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1998 | 150 | 0.010 |
Why?
|
| Testis | 1 | 1999 | 207 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 652 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1997 | 98 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1998 | 611 | 0.010 |
Why?
|
| Histones | 1 | 1998 | 197 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1998 | 515 | 0.010 |
Why?
|
| Activating Transcription Factor 1 | 1 | 1996 | 2 | 0.010 |
Why?
|
| Gene Expression | 1 | 1998 | 701 | 0.010 |
Why?
|
| Down-Regulation | 1 | 1997 | 456 | 0.010 |
Why?
|
| Genes, Regulator | 1 | 1994 | 27 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1994 | 148 | 0.010 |
Why?
|
| Leukemia, Experimental | 1 | 1992 | 4 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 1992 | 5 | 0.010 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 1992 | 9 | 0.010 |
Why?
|
| Immune Sera | 1 | 1991 | 56 | 0.010 |
Why?
|
| Antibodies | 1 | 1991 | 144 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1991 | 186 | 0.010 |
Why?
|
| Epitopes | 1 | 1991 | 157 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1971 | 57 | 0.010 |
Why?
|
| Glycolysis | 1 | 1971 | 71 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 1971 | 83 | 0.010 |
Why?
|
| Phospholipids | 1 | 1971 | 70 | 0.010 |
Why?
|
| Spleen | 1 | 1971 | 204 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1991 | 199 | 0.010 |
Why?
|
| Cholesterol | 1 | 1971 | 232 | 0.000 |
Why?
|
| Glucose | 1 | 1971 | 244 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1971 | 403 | 0.000 |
Why?
|
| Oncogene Proteins | 1 | 1987 | 21 | 0.000 |
Why?
|